| pubmed-article:2461962 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2461962 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:2461962 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:2461962 | lifeskim:mentions | umls-concept:C0026896 | lld:lifeskim |
| pubmed-article:2461962 | lifeskim:mentions | umls-concept:C0080103 | lld:lifeskim |
| pubmed-article:2461962 | lifeskim:mentions | umls-concept:C0017349 | lld:lifeskim |
| pubmed-article:2461962 | lifeskim:mentions | umls-concept:C0034792 | lld:lifeskim |
| pubmed-article:2461962 | lifeskim:mentions | umls-concept:C1704632 | lld:lifeskim |
| pubmed-article:2461962 | lifeskim:mentions | umls-concept:C0871261 | lld:lifeskim |
| pubmed-article:2461962 | lifeskim:mentions | umls-concept:C0334094 | lld:lifeskim |
| pubmed-article:2461962 | lifeskim:mentions | umls-concept:C2911692 | lld:lifeskim |
| pubmed-article:2461962 | lifeskim:mentions | umls-concept:C1706817 | lld:lifeskim |
| pubmed-article:2461962 | lifeskim:mentions | umls-concept:C0205369 | lld:lifeskim |
| pubmed-article:2461962 | lifeskim:mentions | umls-concept:C0474643 | lld:lifeskim |
| pubmed-article:2461962 | lifeskim:mentions | umls-concept:C1533691 | lld:lifeskim |
| pubmed-article:2461962 | lifeskim:mentions | umls-concept:C0597551 | lld:lifeskim |
| pubmed-article:2461962 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:2461962 | pubmed:dateCreated | 1989-1-20 | lld:pubmed |
| pubmed-article:2461962 | pubmed:abstractText | To investigate which parts of the acetylcholine receptor are involved in the initiation and development of myasthenia gravis (MG), peptides representing different sequences of the human acetylcholine receptor alpha-subunit were synthesized. These peptides were tested for their ability to stimulate T cells of myasthenic patients and healthy control patients in proliferation assays and to bind to sera antibodies. Three of eight peptides discriminated significantly between the two groups in the proliferation assay, as well as in their ability to bind to serum antibodies. HLA-DR3 and DR5 were associated with proliferative responses to specific AChR peptides in the group of myasthenics. Acetylcholine receptor epitopes that might play a specific role in myasthenia gravis thus were demonstrated. | lld:pubmed |
| pubmed-article:2461962 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461962 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461962 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461962 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461962 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461962 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461962 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461962 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461962 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461962 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461962 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461962 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461962 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461962 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461962 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461962 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461962 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461962 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461962 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461962 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461962 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461962 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461962 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461962 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461962 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461962 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461962 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461962 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461962 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461962 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2461962 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461962 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:2461962 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461962 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461962 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461962 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461962 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461962 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461962 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2461962 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2461962 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:2461962 | pubmed:issn | 0021-9738 | lld:pubmed |
| pubmed-article:2461962 | pubmed:author | pubmed-author:MozesEE | lld:pubmed |
| pubmed-article:2461962 | pubmed:author | pubmed-author:FuchsSS | lld:pubmed |
| pubmed-article:2461962 | pubmed:author | pubmed-author:AbramskyOO | lld:pubmed |
| pubmed-article:2461962 | pubmed:author | pubmed-author:BrautbarCC | lld:pubmed |
| pubmed-article:2461962 | pubmed:author | pubmed-author:SteinmanLL | lld:pubmed |
| pubmed-article:2461962 | pubmed:author | pubmed-author:NeumannDD | lld:pubmed |
| pubmed-article:2461962 | pubmed:author | pubmed-author:RothbardJJ | lld:pubmed |
| pubmed-article:2461962 | pubmed:author | pubmed-author:BrockeSS | lld:pubmed |
| pubmed-article:2461962 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2461962 | pubmed:volume | 82 | lld:pubmed |
| pubmed-article:2461962 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2461962 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2461962 | pubmed:pagination | 1894-900 | lld:pubmed |
| pubmed-article:2461962 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
| pubmed-article:2461962 | pubmed:meshHeading | pubmed-meshheading:2461962-... | lld:pubmed |
| pubmed-article:2461962 | pubmed:meshHeading | pubmed-meshheading:2461962-... | lld:pubmed |
| pubmed-article:2461962 | pubmed:meshHeading | pubmed-meshheading:2461962-... | lld:pubmed |
| pubmed-article:2461962 | pubmed:meshHeading | pubmed-meshheading:2461962-... | lld:pubmed |
| pubmed-article:2461962 | pubmed:meshHeading | pubmed-meshheading:2461962-... | lld:pubmed |
| pubmed-article:2461962 | pubmed:meshHeading | pubmed-meshheading:2461962-... | lld:pubmed |
| pubmed-article:2461962 | pubmed:meshHeading | pubmed-meshheading:2461962-... | lld:pubmed |
| pubmed-article:2461962 | pubmed:meshHeading | pubmed-meshheading:2461962-... | lld:pubmed |
| pubmed-article:2461962 | pubmed:meshHeading | pubmed-meshheading:2461962-... | lld:pubmed |
| pubmed-article:2461962 | pubmed:meshHeading | pubmed-meshheading:2461962-... | lld:pubmed |
| pubmed-article:2461962 | pubmed:meshHeading | pubmed-meshheading:2461962-... | lld:pubmed |
| pubmed-article:2461962 | pubmed:meshHeading | pubmed-meshheading:2461962-... | lld:pubmed |
| pubmed-article:2461962 | pubmed:meshHeading | pubmed-meshheading:2461962-... | lld:pubmed |
| pubmed-article:2461962 | pubmed:year | 1988 | lld:pubmed |
| pubmed-article:2461962 | pubmed:articleTitle | In vitro proliferative responses and antibody titers specific to human acetylcholine receptor synthetic peptides in patients with myasthenia gravis and relation to HLA class II genes. | lld:pubmed |
| pubmed-article:2461962 | pubmed:affiliation | Department of Chemical Immunology, Weizmann Institute of Science, Rehovot, Israel. | lld:pubmed |
| pubmed-article:2461962 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2461962 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2461962 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2461962 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2461962 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2461962 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2461962 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2461962 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2461962 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2461962 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2461962 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2461962 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2461962 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2461962 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2461962 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2461962 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2461962 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2461962 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2461962 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2461962 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2461962 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2461962 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2461962 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2461962 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2461962 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2461962 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2461962 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2461962 | lld:pubmed |
